Harvard Bioscience Inc Net Asset Quality Index
Harvard Bioscience Inc net asset quality index. Harvard Bioscience Inc (HBIO) has a Net Asset Quality Index of 9.7% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $76.29 Million minus total liabilities of $68.87 Million yields net assets of $7.42 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check Harvard Bioscience Inc (HBIO) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Harvard Bioscience Inc (1998–2025)
Net asset quality index of Harvard Bioscience Inc from 1998 to 2025. This chart shows how Harvard Bioscience Inc's Net Asset Quality Index has evolved across 28 annual periods from 1998 to 2025. As of June 2026, the index stands at 9.7%, representing net assets of $7.42 Million against total assets of $76.29 Million USD. See HBIO book value for net asset value and shareholders' equity analysis.
Harvard Bioscience Inc Net Asset Quality Index by Year (1998–2025)
Harvard Bioscience Inc net asset quality index by year from 1998 to 2025. The table below presents the year-by-year Net Asset Quality Index for Harvard Bioscience Inc from 1998 to 2025, covering 28 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Harvard Bioscience Inc market cap and net worth.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 17.2% | $13.73 Million | $80.07 Million | $66.34 Million | ▼ -32.9 pp |
| 2024 | 50.0% | $63.34 Million | $126.64 Million | $63.30 Million | ▼ -3.2 pp |
| 2023 | 53.2% | $73.07 Million | $137.37 Million | $64.29 Million | ▲ +3.5 pp |
| 2022 | 49.7% | $72.22 Million | $145.36 Million | $73.14 Million | ▼ -1.7 pp |
| 2021 | 51.4% | $83.40 Million | $162.34 Million | $78.94 Million | ▲ +2.3 pp |
| 2020 | 49.1% | $76.68 Million | $156.25 Million | $79.57 Million | ▼ -0.5 pp |
| 2019 | 49.6% | $81.69 Million | $164.87 Million | $83.18 Million | ▲ +0.7 pp |
| 2018 | 48.9% | $82.18 Million | $168.07 Million | $85.89 Million | ▼ -25.1 pp |
| 2017 | 74.0% | $80.90 Million | $109.35 Million | $28.45 Million | ▲ +7.0 pp |
| 2016 | 67.0% | $72.20 Million | $107.77 Million | $35.57 Million | ▲ +2.4 pp |
| 2015 | 64.5% | $77.60 Million | $120.22 Million | $42.62 Million | ▼ -5.7 pp |
| 2014 | 70.2% | $95.47 Million | $135.92 Million | $40.45 Million | ▲ +0.5 pp |
| 2013 | 69.8% | $94.48 Million | $135.46 Million | $40.98 Million | ▼ -8.3 pp |
| 2012 | 78.1% | $104.21 Million | $133.48 Million | $29.27 Million | ▲ +2.7 pp |
| 2011 | 75.4% | $95.50 Million | $126.63 Million | $31.14 Million | ▲ +3.1 pp |
| 2010 | 72.3% | $90.25 Million | $124.80 Million | $34.55 Million | ▲ +2.1 pp |
| 2009 | 70.2% | $75.26 Million | $107.23 Million | $31.97 Million | ▼ -11.9 pp |
| 2008 | 82.1% | $66.72 Million | $81.27 Million | $14.55 Million | ▲ +7.1 pp |
| 2007 | 75.0% | $74.14 Million | $98.85 Million | $24.72 Million | ▼ -2.1 pp |
| 2006 | 77.1% | $71.88 Million | $93.23 Million | $21.34 Million | ▲ +2.8 pp |
| 2005 | 74.3% | $68.42 Million | $92.03 Million | $23.62 Million | ▼ -0.3 pp |
| 2004 | 74.6% | $104.36 Million | $139.88 Million | $35.52 Million | ▼ -2.4 pp |
| 2003 | 77.0% | $98.88 Million | $128.43 Million | $29.55 Million | ▼ -5.2 pp |
| 2002 | 82.2% | $88.38 Million | $107.58 Million | $19.20 Million | ▲ +1.0 pp |
| 2001 | 81.1% | $66.81 Million | $82.36 Million | $15.55 Million | ▼ -7.9 pp |
| 2000 | 89.0% | $52.33 Million | $58.81 Million | $6.47 Million | ▲ +50.3 pp |
| 1999 | 38.7% | $7.98 Million | $20.61 Million | $12.63 Million | ▲ +29.3 pp |
| 1998 | 9.4% | $678.00K | $7.22 Million | $6.54 Million | — |